SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-235745
Filing Date
2020-08-31
Accepted
2020-08-31 10:12:59
Documents
3
Period of Report
2020-08-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d931852d8k.htm 8-K 16738
2 EX-99.1 d931852dex991.htm EX-99.1 27150
3 GRAPHIC g931852ex99-1logo.jpg GRAPHIC 2893
  Complete submission text file 0001193125-20-235745.txt   49281
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Filer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39059 | Film No.: 201150148
SIC: 3841 Surgical & Medical Instruments & Apparatus